Most patients who have sleep apnea do not know it. They wake up tired, reach for coffee, push through the day, and put the fatigue down to stress or a bad night. Their partner may have mentioned snoring. They may have noticed waking up with headaches or feeling unrested despite spending eight hours in bed. But without a formal diagnosis, the condition continues unchecked, and the damage it does to the body accumulates quietly over the years.
Sleep apnea is not just a sleep disorder. It is a systemic condition with consequences that reach well beyond poor rest.
Sleep apnea is characterised by multiple episodes of apnea or hypopnea during sleep, which cause nocturnal arousals, gasping for breath, daytime sleepiness, irritability, forgetfulness, fatigue, and recurrent headaches.
Every time breathing stops, a decrease in oxygen levels occurs in the blood. This is sensed by the brain and initiates a partial awakening to begin breathing. Typically, the person does not fully wake, but sufficiently to break up sleep and hinder the maintenance of the deeper, recuperative stages. This happens dozens, sometimes hundreds, of times a night. By morning, the body has been under repeated physiological stress throughout what should have been a period of recovery.
Obstructive sleep apnea increases the risk for coronary artery disease, hypertension, atrial fibrillation, and cardiovascular mortality. The mechanism behind this is not hard to understand. Every apnea episode triggers a surge in sympathetic nervous system activity, blood pressure spikes, and oxygen desaturation. Repeated thousands of times a night over the years, this places an enormous cumulative strain on the heart and blood vessels.
Considerable evidence supports an independent association between obstructive sleep apnea and cardiovascular disease, which is particularly strong for systemic arterial hypertension and growing for ischaemic heart disease, stroke, heart failure, atrial fibrillation, and cardiac sudden death.
Sleep apnea and heart disease are not a theoretical association. It is one of the most consistently documented relationships in sleep medicine, and it is why cardiologists increasingly screen for sleep apnea in patients with difficult-to-control hypertension or recurrent atrial fibrillation.
Obstructive sleep apnea health risks mainly affect patients with obesity, type 2 diabetes, hypertension, and dyslipidaemia, and are strongly associated with cardiovascular complications. Based on the bidirectional relationship between type 2 diabetes and sleep apnea, each condition represents a risk factor for the other.
Disrupted sleep impairs insulin sensitivity and glucose regulation, worsening metabolic control in people who already have diabetes and pushing those with prediabetes further toward frank disease. Oxygen drops also occur repeatedly during apneas, further contributing to oxidative stress and systemic inflammation, which in turn contribute to atherosclerosis and metabolic dysfunction independently of weight.
The most common risk factor for sleep apnea is obesity, meaning that sleep apnea affects more than 40% of individuals with a body mass index greater than 30. Fat around the neck and throat decreases the size of the upper airway and increases the risk of it collapsing during sleep.
Other factors for sleep apnea are:
The prevalence of sleep apnea is significantly increasing due to the epidemic of obesity, physical inactivity, and diabetes, which are important risk factors for its development and persistence. Yet despite this, the condition remains massively underdiagnosed. Many people with significant sleep apnea have never been tested, and in clinical settings, the condition is often not considered until cardiovascular complications are already present.
Undiagnosed sleep apnea means years of untreated oxygen deprivation, uncontrolled cardiovascular stress, and worsening metabolic dysfunction. It also means impaired driving and occupational performance from chronic daytime sleepiness, a risk that extends beyond the individual.
The most commonly reported symptoms of obstructive sleep apnea include loud, persistent snoring, witnessed pauses in breathing, waking with a dry mouth or sore throat, morning headaches, and significant daytime sleepiness despite adequate time in bed. Many patients also report waking repeatedly during the night, poor concentration, memory difficulties, and low mood.
Crucially, not everyone with sleep apnea snores loudly or appears obviously sleepy. A certain number of patients may have only moderate daytime symptoms and severe oxygen desaturations during sleep. One of the reasons it is so often missed.
The most common diagnosis for sleep apnea heart disease is made through a sleep study, performed in a sleep lab or by a validated home sleep study device, which determines the severity of the sleep apnea condition. The severity is based on the apnea-hypopnea index, which states how many times you stop or have light breathing during your sleep.
If patients have been diagnosed with moderate-to-severe sleep apnea, the most effective treatment is continuous positive airway pressure therapy. For milder cases, lifestyle changes, like weight loss, not drinking alcoholic beverages before sleeping and lying on the side, are helpful and in more severe cases can be used along with medical treatment.
Some risk factors for sleep apnea are obesity, age, male gender, alcohol consumption and airway anatomy. Undiagnosed sleep apnea has documented serious health effects beyond tiredness, such as hypertension, coronary artery disease, atrial fibrillation, stroke and type 2 diabetes.
Sleep apnea and heart disease associations are among the most consistently documented in sleep medicine. Anyone suffering from prolonged fatigue, morning headaches, pauses in breathing while sleeping, or uncontrolled blood pressure must consult a doctor about the possibility of sleep apnea and seek formal testing.